Moreover, also in NSCLC the expression of NKp46 as well as NKp30 had a predictive role in patient prognosis; in particular, a lower expression of them is associated with a low chance of progression-free survival [63,64]. Here, NCR1 is linked to non-small cell lung carcinoma.